The Bristol-Myers Squibb Co. has agreed to license its AIDS drug Reyataz free of charge to two Third World generic drug manufacturers.
The Bristol-Myers Squibb Co. has agreed to license its AIDS drug Reyataz free of charge to two Third World generic drug manufacturers.